According to the IMARC Group, Sepsis refers to the medical condition in which the immune system releases various chemicals into the bloodstream. This condition triggers hyper inflammation and results in the formation of blood clots in the body. Sepsis diagnostics involve multiple technologies that help to identify symptoms to fight infections based on the contamination of bacteria, viruses and fungi. Sepsis can be diagnosed through procedures, such as molecular diagnosis, immunoassays, microfluidics, biomarkers, and flow cytometry.
The global sepsis diagnostics market is primarily driven by the increasing prevalence of hospital-acquired infections (HAIs), especially among the geriatric population, infants and patients suffering from chronic illness. Along with this, the rising cases of infectious diseases due to various antibiotic-resistant bacteria, gram-positive bacteria and gram-negative bacilli are also propelling the market growth. Moreover, the integration of multiple test results from various platforms with advanced data analytics tools is expected to increase the adoption of sepsis diagnostics in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global sepsis diagnostics market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, diagnosis, product, mode of testing, technology, pathogen and end user.
Breakup by Diagnosis:
Automated Diagnostics
Conventional Diagnostics
Breakup by Product:
Instruments
Assay Kits and Reagents
Blood Culture Media
Software
Breakup by Mode of Testing:
Laboratory Tests
Point-of-Care Tests
Breakup by Technology:
Molecular Diagnostics
Immunoassays
Biomarkers
Flow Cytometry
Microfluidics
Blood Culture
Breakup by Pathogen:
Bacterial Sepsis
Gram-Positive Bacterial Sepsis
Gram-Negative Bacterial Sepsis
Viral Sepsis
Fungal Sepsis
Others
Breakup by End User:
Diagnostic Clinics
Hospitals
Research Laboratories
Breakup by Region:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Others
Asia Pacific
China
India
Japan
Australia
Singapore
Others
Latin America
Brazil
Mexico
Argentina
Others
Middle East and Africa
Saudi Arabia
United Arab Emirates
South Africa
Others
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Becton, Dickinson and Company (BD), biomerieux SA, Bruker Corporation, EKF Diagnostics Holding Plc, Epic Systems Corporation, Luminex Corporation, Roche Holding AG, Sysmex Corporation, and T2 Biosystems Inc.
Browse Related Report
https://www.imarcgroup.com/nucleic-acid-testing-market
https://www.imarcgroup.com/polyvinyl-alcohol-technical-material-market-r...
https://www.imarcgroup.com/digestive-health-products-market
https://www.imarcgroup.com/transformerless-ups-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group